Harvard Business Review chooses articles by Paradox Strategies authors for exclusive book collections

Writing by Linda Hill and Taran Swan featured in 'HBR at 100' and 'HBR's 10 Must Reads 2023'

Articles by Linda Hill and Taran Swan are featured in 'HBR at 100' and 'HBR's 10 Must Reads 2023'

Two articles by Paradox Strategies authors have been selected for inclusion in exclusive book collections by Harvard Business Review.

In a book released earlier this summer, HBR at 100: The Most Influential and Innovative Articles from Harvard Business Review’s First Century, editors celebrated the publication’s 100th anniversary with a commemorative volume of what they are calling the most influential voices on innovative topics since its inception. Linda Hill’s 2007 HBR article, Becoming the Boss, about becoming a first-time manager, was selected as among “the most definitive management ideas in a century.”

For decades, Linda has studied how star performers transition into management. “The shelves are lined with books describing effective and successful leaders. But very few address the challenges of learning to lead, especially for the first-time manager,” she notes. This article represents the culmination of her decades of research and case studies that have since fueled leadership development initiatives designed to make that difficult transition much easier. It was also an important precursor to her definitive management book, Being the Boss.

In a second book collection, an article by Paradox Strategies’ Linda Hill and Taran Swan with Harvard Business School research associate Emily Tedards has been selected for the highly curated upcoming publication of HBR’s 10 Must Reads 2023: The Definitive Management Ideas of the Year from Harvard Business Review – coming in October.

The article, Drive Innovation with Better Decision-Making, featured in HBR’s November-December 2021 edition, provides best practices for decision-making drawing on the story of the transformation at Pfizer’s Global Clinical Supply, which would go on to play a critical role supporting the rapid development of the pharma giant’s Covid vaccine.